1-1 of 1
Howard Goldsweig, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of S-trans, Trans-farnesylthiosalicylic Acid (FTS), a Novel Oral Ras Inhibitor, in Patients with Refractory Hematologic Malignancies.

Gautam Borthakur, MD, Farhad Ravandi, MD, Susan O’Brien, MD, Miloslav Beran, MD, Betsy Williams, RN, Howard Goldsweig, MD, Francis Giles, MD
Journal: Blood
Blood (2007) 110 (11): 1600.
https://doi.org/10.1182/blood.V110.11.1600.1600
Published: 2007